

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | — | — | 2 | — | — | 2 |
| Lung neoplasms | D008175 | — | C34.90 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
| Drug common name | Tariquidar |
| INN | tariquidar |
| Description | Tariquidar is a member of benzamides. |
| Classification | Small molecule |
| Drug class | multidrug resistance inhibitors: quinoline derivatives |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2 |
| PDB | — |
| CAS-ID | 206873-63-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL348475 |
| ChEBI ID | — |
| PubChem CID | 148201 |
| DrugBank | DB06240 |
| UNII ID | J58862DTVD (ChemIDplus, GSRS) |

